References
- Matsuda LA, Lolait SJ, Brownstein MJ. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561–564
- Caswell A. Marijuana as medicine. Medical Journal of Australia 1991; 156: 497–498
- Ames F. A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses. Journal of Mental Science 1958; 104: 972–999
- Gaonis Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American Chemistry Society 1964; 86: 1646–1648
- Isbell H, Gorodetzsky CW, Jasinski D, Claussen V, Spulak FV, Korte F. Effects of delta-9-trans-tetrahydrocannabidiol in man. Psychopharmalogica 1967; 11: 184–188
- Thacore VR, Shukla SRP. Cannabis psychosis and paranoid schizophrenia. Archives of General Psychiatry 1976; 33: 383–386
- Tunving K. Psychiatric aspects of cannabis use in adolescents and young adults. Pediatrician 1987; 14: 83–91
- Thomas H. Psychiatric symptoms in cannabis users. British Journal of Psychiatry 1993; 163: 141–149
- Rottanburg D, Robins AH, Ben-Arie O, Teggin A, Elk R. Cannabis-associated psychosis with hypomanic features. Lancet. 1982, ii: 1364-1366
- Wing JK, Cooper JE, Sartorius N. Measurement and classification of psychiatric symptoms. Cambridge: Cambridge University Press,. 1976
- Thornicroft G. Cannabis and psychosis: is there epidemiological evidence for an association?. British Journal of Psychiatry 1990; 157: 25–33
- Negrete JC, Knapp WP, Douglas DE, Smith WB. Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychological Medicine 1986; 16: 515–520
- Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 1994; 51: 273–279
- Tennant FS, Groesbeck CJ. Psychiatric effects of hashish. Archives of General Psychiatry 1972; 27: 133–136
- Andreason S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet. 1987, ii: 1483-1485
- Johnson BA, Smith BL, Taylor P. Cannabis and schizophrenia. Lancet. 1988, i:592-593
- Negrete JC. Cannabis and schizophrenia. British Journal of Addiction 1989; 84: 349–351
- Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A. Schizophrenia: manifestations, incidence and course in different cultures. Psychological Medicine,. 1992, Monograph 20
- Ghodse AH. Cannabis psychosis. British Journal of Addiction 1986; 81: 473–78
- Talbott JA., Teague JW. Marihuana psychosis. Journal of the American Medical Association 1969; 210: 299–302
- Chopra GS, Smith JW. Psychotic reactions following cannabis use in East Indians. Archives of General Psychiatry 1974; 30: 24–27
- Co BT, Goodwin DW, Gado M, Mikhael M, Hill SY. Absence of cerebral atrophy in chronic cannabis users: evaluation by computerized axial tomography. Journal of the American Medical Association 1977; 237: 1229–1230
- Kuehnle J, Mendelson JH, Davis KR, New PFJ. Computed tomographic examination of heavy marijuana smokers. Journal of the American Medical Association 1977; 237: 1231–1232
- Harper JW, Heath RG, Myers WA. Effects of Cannabis sativa on ultrastructure of the synapse in monkey brain. Journal of Neuroscience Research 1977; 3: 87–93
- Ames FR, Brownell B, Zuurmond TJ. Effects of oral administration of Cannabis sativa (dagga) on chacma baboons (Papio ursinus). South African Medical Journal 1979; 55: 1127–1132
- Hollister LE. Cannabis 1988. Acta Psychiatrica Scandinavica 1988; 78: 108–118
- Wert RC, Raulin ML. The chronic cerebral effects of cannabis use. II. Psychological findings and conclusions. International Journal of Addiction 1986; 21: 629–642
- Solowij N, Michie PT, Fox AM. Differential impairments of selective attention due to frequency and duration of cannabis use. Biological Psychiatry 1995; 152: 213–219